Search
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Quench Bio emerges with $50M to treat severe inflammatory diseases
LabCentral’s Measures in Response to COVID-19 for Our Community
Disclaimer: The views, thoughts, and opinions…
Our Response to the Massachusetts Essential Services Order
Like you, the LabCentral team is actively…
LabCentral Virtual Event Series: Innovation and Biotech in the Time of COVID-19
Disclaimer: the views, thoughts, and opinions…
COVID-19 Updates: Close Contact Rules, Face Masks and Virtual Events
We’d like to thank our community for their…